Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oral7 USA Operations is the North American distribution and operational arm of the Oral7 brand, which specializes in advanced enzymatic oral care solutions. The company provides a range of products, including toothpastes, mouthwashes, and gels, specifically formulated to manage the symptoms of Xerostomia, commonly known as dry mouth. These products utilize a proprietary blend of natural enzymes—Lysozyme, Lactoferrin, Glucose Oxidase, and Lactoperoxidase—to mimic the protective functions of healthy saliva and maintain a balanced oral microbiome. By neutralizing acids and promoting a healthy pH, Oral7 helps prevent tooth decay and gum disease in patients with compromised salivary flow. The brand is recognized for its alcohol-free and sugar-free formulations, making it a preferred choice for individuals with sensitive oral tissues or those undergoing medical treatments like chemotherapy. Oral7 USA Operations focuses on expanding the availability of these clinical-grade oral health products to consumers and dental professionals across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oral7 USA Operations.